Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00603369 · ClinicalTrials.gov registry record · Phase 1

HIV, Abuse, and Psychiatric Disorders Among Youth

A Phase 1 study, sponsored by Rhode Island Hospital.

Completed
Registry status
Phase 1
Development phase
212
Enrollment target

NCT00603369: Completed Phase 1 study, sponsored by Rhode Island Hospital.

NCT00603369 is a Phase 1 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 212 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (253% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00603369, a Phase 1 study, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
Phase 1
Development phase
212 participants
Enrollment target

Study Summary

One subgroup of adolescents at particular risk for HIV is those with psychiatric disorders. Furthermore, those with histories of sexual abuse have been found to have riskier attitudes, poorer sexual communication skills, and less consistent condom use than non-abused peers. This study implemented and evaluated interventions for adolescents in intensive psychiatric treatment settings, particularly those with histories of sexual abuse. It is hypothesized that those participating in the intervention that addresses affect management and cognitive monitoring strategies will show fewer HIV-risk related behaviors and attitudes at posttest than peers in an information-based intervention.

Interventions

  • BEHAVIORAL group intervention

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 1999-09
Est. Completion 2007-12
Phase Phase 1
Rhode Island Hospital

130 total trials

What the finished NCT00603369 record still lists

NCT00603369 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (253% higher).

The record links to 0 conditions, and to 1 intervention - of which group intervention is the first listed.

NCT00603369 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00603369 about?

NCT00603369 is a clinical study titled "HIV, Abuse, and Psychiatric Disorders Among Youth". One subgroup of adolescents at particular risk for HIV is those with psychiatric disorders. Furthermore, those with histories of sexual abuse have been found to have riskier attitudes, poorer sexual communication skills, and less consistent condom use than non-abused peers. This study implemented an...

What is the current status of trial NCT00603369?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 212 participants. The study started on 1999-09. Estimated completion is 2007-12.

What interventions are being tested in trial NCT00603369?

The interventions under investigation include: group intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00603369?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00603369's enrollment target sits among peer trials

212 245th of 2000 higher than 1,756 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

  • NCT06456593 · 212 participants · Phase 2

    Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00603369, the US trial registry maintained by the National Library of Medicine. NCT00603369 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.